Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer's disease

Laboratory Investigation

Volumn 77, Issue 3, 1997, Pages 197-209

  Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CARRIER PROTEIN; GLUTAMIC ACID; MESSENGER RNA;

ALZHEIMER DISEASE; COGNITIVE DEFECT; HUMAN; NERVE CELL LESION; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; HUMANS; NERVE DEGENERATION; NERVOUS SYSTEM;

EID: 0030880345     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (166)

1. Abe K, Tanzi RE, and Kogure K (1991). Selective induction of Kunitz-protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett 125:172-174.
2. Alzheimer's Disease Collaborative Group (1995). The structure of the presenilin 1(S182) gene and identification of six novel mutations in early onset AD families. Nature Genet 11:219-222.
3. Aral H, Lee VM-Y, Messinger ML, Greenberg BD, Lowery DE, and Trojanowski JQ (1991). Expression patterns of β-amyloid precursor protein (β-APP) in neural and nonneural tissues from Alzheimer's disease and control subjects. Ann Neurol 30:686-693.
4. Arriagada PV, Growdon JH, Hedley-Whyte ET, and Hyman BT (1992a). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42:631-639.
5. Arriagada PV, Marzloff K, and Hyman BT (1992b). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42:1681-1688.
6. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, and Amara SG (1994). Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14:5559-5569.
7. Askanas V, Engel WK, and Alvarez RB (1992). Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions. Neurosci Lett 143:96-100.
8. Balcar VJ and Li Y (1992). Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life Sci 51:1467-1478.
9. Beach TG, Walker R, and McGeer EG (1989). Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2:420-436.
10. Behl C, Davis J, Lesley R, and Schubert D (1994). Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
11. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, and Yager D (1996). Familial Alzheimer's disease-linked presenilin 1 variants elevate Ab1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005-1013.
12. Bowes MP, Masliah E, Chen B-L, Otero D, Zivin J, and Saitoh T (1994). Reduction of neurological damage by a trophic peptide segment of the amyloid β/A4 protein (APP). Exp Neurol 129:1-8.
13. Braak H and Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
14. Breen KC, Bruce M, and Anderton BH (1991). Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J Neurosci Res 28:90-100.
15. Butterfield DA, Hensley K, Harris M, Mattson MP, and Carney J (1994). β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease. Biochem Biophys Res Commun 200:710-715.
16. Card JP, Meade RP, and Davis LG (1988). Immunocytochemical localization of the precursor of the precursor protein for β-amyloid in the rat central nervous system. Neuron 1:835-846.
17. Casado M, Bendahan A, Zafra F, Danbolt NC, Aragon C, Gimenez C, and Kanner BI (1993). Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J Biol Chem 268:27313-27317.
18. Checler F (1995). Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem 65:1431-1444.
19. Chen M and Yankner BA (1991). An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types. Neurosci Lett 125:223-226.
20. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Liberburg I, and Selkoe DJ (1992). Mutation in the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-674.
21. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Subert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Hong Y, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St. George Hyslop P, and Selkoe D (1997). Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med 3:67-72.
22. Clark RF and Goate AM (1993). Molecular genetics of Alzheimer's disease. Arch Neurol 50:1164-1172.
23. Cole GM, Masliah E, Huynh TV, DeTeresa R, Terry RD, Okudea C, and Saitoh T (1989). An antiserum against amyloid β-protein precursor detects a unique peptide in Alzheimer brain. Neurosci Lett 100:340-346.
24. Cowburn R, Hardy J, Roberts P, and Briggs R (1988). Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease. Neurosci Lett 86:109-113.
25. Cowburn RF, Hardy JA, and Roberts PJ (1990). Glutamatergic neurotransmission in Alzheimer's disease. Biochem Soc Trans 18:390-392.
26. Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, and Perry G (1991). Senile plaque neuntes in Alzheimer disease accumulate amyloid precursor protein. Proc Nat Acad Sci USA 88:7552-7556.
27. Cummings BJ and Cotman CW (1995). Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 346:1524-1528.
28. Davenport RW, Dou P, Rehder V, and Kater SB (1993). A sensory role for neuronal growth cone filopodia. Nature 361:721-724.
29. De Strooper B, Craessaerts K, Dewachter I, Moechars D, Greenberg B, Van Leuven F, and Van Den Berghe H (1995). Missorting of amyloid precursor protein in MDCK cells. J Biol Chem 270:4058-4065.
30. DeKosky ST, and Scheff SW (1990). Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 27:457-464.
31. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, and Yen SC (1988). Alzheimer disease: A double immunohistochemical study of senile plaques. Am J Pathol 132:86-101.
32. Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Muller-Hill B, Masters CL, and Beyreuther K (1988). Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J 7:949-957.
33. Eccles JC (1981). The modular operation of the cerebral neocortex considered as the material basis of mental events. Neuroscience 6:1839-1856, 1-36.
34. Eccles JC (1984). The cerebral neocortex: A theory of its operation. In: Jones EG and Peters A, editors. Cerebral cortex, vol 2: Functional properties of cortical cells. New York, Plenum Press.
35. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, and Ward PJ (1990). Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122-1124.
36. Ferreira A, Caceres A, and Kosik K (1993). Intraneuronal compartments of the amyloid precursor protein. J Neurosci 13:3112-3123.
37. Furukawa K, Barger SW, Blalock E, and Mattson MP (1996a). Activation of K+ channels and suppression of neural activity by secreted β-amyloid precursor protein. Nature 379:74-78.
38. Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, and Mattson MP (1996b). Increased activity regulating and neuroprotective efficacy of a-secretase-derived secreted amyloid precursor protein conferred by a c-terminal heparin-binding domain. J Neurochem 67:1882-1892.
39. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemes J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, and Zhao J (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527.
40. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Guiffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Williamson R, Rossor M, Owen M, and Hardy J (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
41. Golde TE, Estus S, Younkin LH, Selkoe DJ, and Younkin SG (1992). Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728-730.
42. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, and Hyman BT (1996). Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16:4491-4500.
43. Goodman Y and Mattson MP (1994). Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp Neurol 128:1-12.
44. Greenamyre JT and Porter RHP (1994). Anatomy and physiology of glutamate in the CNS. Neurology 44(Suppl):S7-S13.
45. Haass C, Hung AY, and Selkoe DJ (1991). Processing of β-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci 11:3783-3793.
46. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski B, Liberburg I, Koo EH, Schenk D, Teplow DB, and Selkoe DJ (1992). Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322-327.
47. Haass C, Koo E, Capell A, Teplow D, and Selkoe DJ (1995). Polarized sorting of β-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol 128:537-547.
48. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67:277-286.
49. Heinonen O, Soininen H, Sorvari H, Kosunene O, Paljarvi L, Koivisto E, and Riekkinen PJ (1995). Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neurosci 64:375-384.
50. Hof PR and Morrison JH (1991). Neocortical neuronal sub-populations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp Neurol 111:293-301.
51. Hof PR and Morrison JH (1994). The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. In: Terry RD, Katzman R, and Bick KL, editors. Alzheimer's disease. New York: Raven Press, 197-229.
52. Hung AY, Koo EH, Haass C, and Selkoe DJ (1992). Increased expression of β-amyloid precursor during neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci USA 89:9439-9443.
53. Hyman BT, Van Hoesen GW, Kromer LJ, and Damasio AR (1986). Perforant pathway changes in the memory impairment of Alzheimer's disease. Ann Neurol 20:472-481.
54. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, and Ihara I (1994). Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species in A beta 42(43). Neuron 13:45-53.
55. Kanai Y and Hediger MA (1992). Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360:467-471.
56. Kanai Y, Smith CP, and Hediger MA (1993). The elusive transporters with a high affinity for glutamate. Trends Neurosci 16:359-365.
57. Kanai Y, Stelzner M, Nubberg S, Khawaja S, Hebert SC, Smith CP, and Hediger MA (1994). The neuronal and epithelial human high affinity glutamate transporter. J Biol Chem 269:20599-20606.
58. Kanai Y, Nussberger S, Romero MF, Boron WF, Hebert SC, and Hediger MA (1995). Electrogenic properties of the epithelial and neuronal high affinity glutamate transporter. J Biol Chem 270:16561-16568.
59. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Maulthaup G, Beyreuther K, and Muller-Hill B (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
60. Kawarabayashi T, Shoji M, Harigaya Y, Yamaguchi H, and Hirai S (1991). Expression of APP in the early stage of brain damage. Brain Res 563:334-338.
61. Kibbey MC, Jucker M, Weeks BS, Neve RL, Van Nostrand WE, and Kleinman HK (1993). β-amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc Natl Acad Sci USA 90:10150-10153.
62. Kitaguchi N, Takahashi Y, Oishi K, Shiojiri S, Tokushima Y, Utsunomiya T, and Ito H (1990). Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease: Different properties compared with protease nexin I. Biochim Biophys Acta 1038:105-113.
63. Klier FG, Cole G, Stallcup W, and Schubert D (1990). Amyloid β-protein precursor is associated with extracellular matrix. Brain Res 515:336-342.
64. Knauer MF, Orlando RA, and Glabe CG (1996). Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP). Brain Res 740:6-14.
65. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, and Price DL (1990). Precursor of amyloid protein in Alzheimer's disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 87:1561-1565.
66. Koo EH, Park L, and Selkoe DJ (1993). Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc Natl Acad Sci USA 90:4749-4752.
67. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argaves WS, Tanzi RE, Hyman BT, and Strickland DK (1995). LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82:331-340.
68. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, Hollister RD, Hallmark OG, Mancini R, and Felsenstein KM (1996). Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med 2:224-229.
69. LeBlanc AC, Papadopoulos M, Belair C, Chu W, Crosato M, Powell J, and Goodyer CG (1997). Processing of amyloid precursor protein in human primary neuron and astrocyte cultures. J Neurochem 68:1183-1190.
70. Li S, Mallory M, Alford M, Tanaka S, and Masliah E (in press, 1997). Glutamate transporter alterations in Alzheimer's disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol.
71. Liu X, Erikson C, and Brun A (1996). Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. Dementia 7:128-134.
72. Lo A, Haass C, Wagner S, Teplow D, and Sisodia S (1994). Metabolism of the "Swedish" amyloid precursor protein variant in Madin-Darby canine kidney cells. J Biol Chem 269:30966-30973.
73. Lorenzo A and Yankner BA (1994). β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91:12243-12247.
74. Luo L, Tully T, and White K (1992). Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron 9:595-605.
75. Manfras BJ, Rudert WA, Trucco M, and Boehm BO (1994). Cloning and characterization of a glutamate transporter cDNA from human brain and pancreas. Biochim Biophys Acta 1195:185-188.
76. 2+ homeostasis and cell death. J Neurosci 15:6239-6249.
77. Marquez-Sterling NR, Lo ACY, Sisodia SS, and Koo EH (1997). Trafficking of cell-surface β-amyloid precursor protein: Evidence that a sorting intermediate participates in synaptic vesicle recycling. J Neurosci 17:140-151.
78. Martin LJ, Cork LC, Koo EH, Sisodia SS, Weidemann A, Beyreuther K, Masters C, and Price DL (1989). Localization of amyloid precursor protein (APP) in brains of young and aged monkeys. Soc Neurosci Abstr 15:23.
79. Martin LJ, Pardo CA, Cork LC, and Price DL (1994). Synaptic pathology and glial reponses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 145:1358-1381.
80. Masliah E, Mallory M, Hansen L, Alford M, Albright T, DeTeresa R, Terry RD, Baudier J, and Saitoh T (1991a). Patterns of aberrant sprouting in Alzheimer's disease. Neuron 6:729-739.
81. Masliah E, Mallory M, Hansen L, Alford M, Albright T, Terry R, Shapiro P, Sundsmo M, and Saitoh T (1991b). Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol 83:12-20.
82. Masliah E, Mallory M, Ge N, and Saitoh T (1992a). Amyloid precursor protein is localized in growing neurites of neonatal rat brain. Brain Res 593:323-328.
83. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R, Baudier J, and Saitoh T (1992b). Localization of amyloid precursor protein in GAP43-imrnunoreactive aberrant sprouting neuntes in Alzheimer's disease. Brain Res 574:312-316.
84. Masliah E and Terry R (1993). The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol 3:77-85.
85. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, and Terry R (1993). An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol 142:871-882.
86. Masliah E and Terry R (1994). The role of synaptic pathology in the mechanisms of dementia in Alzheimer's disease. Clin Neurosci 1:192-198.
87. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, and Terry R (1994). Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174:67-72.
88. Masliah E (1995). Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10:509-519.
89. Masliah E, Mallory M, Alford M, Ge N, and Mucke L (1995). Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice. In: Iqbal K, Mortimer JA, Winblad B, and Wisniewski HM, editors. Research advances in Alzheimer's disease and related disorders. New York: John Wiley & Sons, Ltd, 405-414.
90. Masliah E, Alford M, Salmon D, DeTeresa R, Mallory M, and Hansen L (1996a). Deficient glutamate transporter activity in Alzheimer's disease is associated with accumulation of brain spectrin degradation products and neurodegeneration. Ann Neurol 40:759-766.
91. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, and Games D (1996b). Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J Neurosci 16: 5795-5811.
92. Masliah E, Raber J, Alford M, Mallory M, Mattson MP, Westland C, and Mucke L (in press, 1997a). Amyloid protein precursor stimulates excitatory amnino acid transport: Possible involvement in neuroprotective in vivo functions. J Biol Chem.
93. Masliah E, Westland CE, Abraham CR, Mallory M, Veinbergs I, Rockenstein EM, and Mucke L (1997b). Amyloid precursor protein protects neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience 78: 135-141.
94. Masters CL, Multhaup G, Simms G, Pottglesser J, Martins RN, and Beyreuther K (1985). Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757-2763.
95. Mattson MP (1994). Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J Neurobiol 25:439-450.
96. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, and Rydel RE (1993a). Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10:243-254.
97. Mattson MP, Cheng B, and Smith-Swintosky VL (1993b). Mechanisms of neurotrophic factor protection against calcium- and free radical-mediated excitotoxic injury: Implications for treating neurodegenerative disorders. Exp Neurol 124:89-95.
98. Mattson MP, Tomaselli KJ, and Rydel RE (1993c). Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 621:35-49.
99. Mobley WC, Neve RL, Prusiner SB, and McKinley MP (1988). Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. Proc Natl Acad Sci USA 85:9811-9815.
100. Mucke L, Masliah E, Johnson WB, Ruppe MD, Rockenstein EM, Forss-Petter S, Pietropaolo M, Mallory M, and Abraham CR (1994). Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res 666:151-167.
101. Mucke L, Abraham CR, Ruppe MD, Rockenstein EM, Toggas SM, Alford M, and Masliah E (1995). Protection against HIV-1 gp120-induced brain damage by neuronal overexpression of human amyloid precursor protein (hAPP). J Exp Med 181: 1551-1556.
102. Nakamura Y, Takeda M, Niigawa H, Hariguchi S, and Nishimura T (1992). Amyloid beta-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Lett 136:95-98.
103. Ohgami T, Kitamoto T, and Tataishi J (1992). Alzheimer's amyloid precursor protein accumulates within axonal swellings in human brain lesions. Neurosci Lett 136:75-78.
104. Oltersdorf T, Fritz LC, Schenk DB, Lieberburg I, Johnson-Wood KL, Beattie EC, Ward PJ, Blacher RW, Dovey HF, and Sinha S (1989). The secreted form of the Alzheimer's amyloid precursor with the Kunitz domain is protease nexin-II. Nature 341:144-147.
105. Otsuka N, Tomonaga M, and Ikeda K (1991). Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res 568:335-338.
106. Palmert M, Siedlak S, Podlisny M, Greenberg B, Shelton E, Chan H, Usiak M, Selkoe DJ, Perry G, and Younkin S (1989). Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein. Biochem Biophys Res Commun 165:182-188.
107. Perry EK, McKeith I, and Thompson P (1991). Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's diseas, and Alzheimer's disease. Ann NY Acad Sci 640:197-202.
108. Perry EK, Perry RH, Blessed G, and Tomlinson BE (1977). Neurotransmitter enzyme abnormalities in senile dementia: CAT and GAD activities in necropsy tissue. J Neurol Sci 34:247-265.
109. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E, and Kanner BI (1992). Cloning and expression of a rat brain L-glutamate transporter. Nature 360:464-467.
110. Price DL, Sisodia SS, and Gandy SE (1995). Amyloid beta amyloidosis in Alzheimer's disease. Curr Opin Neurol 8:268-274.
111. Quon D, Catalano R, and Cordell B (1990). Fibroblast growth factor induces beta-amyloid precursor mRNA in glial but not neuronal cultured cells. Biochem Biophys Res Commun 167:96-102.
112. Rebeck GW, Reiter JS, Strickland DK, and Hyman BT (1993). Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575-580.
113. Roberts GW, Nash M, Ince PG, Royston MC, and Gentleman SM (1993). On the origin of Alzheimer's disease: A hypothesis. NeuroReport 4:7-9.
114. Roch J-M, Masliah E, Roch-Levecq A-C, Sundsmo MP, Otero DAC, Veinbergs I, and Saitoh T (1994). Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc Natl Acad Sci USA 91:7650-7654.
115. Roch J-M, Shapiro P, Sundsmo MP, Otero DAC, Refolo LM, Robakis NK, and Saitoh T (1992). Bacterial expression, purification, and functional mapping of the amyloid β/A4 protein precursor. J Biol Chem 267:2214-2221.
116. Rockenstein EM, McConlogue L, Tan H, Power M, Masliah E, and Mucke L (1995). Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem 270:28257-28267.
117. Rogers J, Luber-Narod J, Styren SD, and Civin WH (1988). Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9:339-349.
118. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, and Schielke JP (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
119. Rothstein JD, Jin L, Dykes-Hoberg M, and Kuncl RW (1993). Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 90:6591-6595.
120. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, and Kuncl RW (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73-84.
121. Saitoh T, Kang D, Mallory M, DeTeresa R, and Masliah E (1996). Glial cells in Alzheimer's disease: Preferential effect of APOE risk on scattered microglia. Gerontology 43:109-118.
122. Saitoh T, Roch J-M, Lin LW, Ninomiya H, Otero DAC, Yamamoto K, and Masliah E (1994). The biological function of amyloid β/A4 protein precursor. In: Masters CL, Beyreuther K, Trillet M, and Christen Y, editors. Amyloid protein precursor in development, aging and Alzheimer's disease (Foundation IPSEN). New York: Springer-Verlag, 90-99.
123. Saitoh T, Sundsmo M, Roch J-M, Kimura N, Cole G, Schubert D, Hersdorf T, and Schenk DB (1989). Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell 58:615-622.
124. Samuel W, Masliah E, and Terry R (1994). Hippocampal connectivity and Alzheimer's dementia: Effects of pathology in a two-component model. Neurology 44:2081-2088.
125. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, and Roses AD (1993). Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
126. Schubert D, Cole G, Saitoh T, and Oltersdorf T (1989a). Amyloid β protein precursor is a mitogen. Biochem Biophys Res Commun 162:83-88.
127. Schubert D, Jin L-W, Saitoh T, and Cole G (1989b). The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion. Neuron 3:689-694.
128. Schubert D, La Corbiere M, Saitoh T, and Cole G (1989c). Characterization of an amyloid β precursor protein that binds heparin and contains tyrosine sulfacte. Proc Natl Acad Sci USA 86:2066-2069.
129. Schubert W, Prior R, Weidemann A, Dircksen H, Multhaup G, Masters CL, and Beyreuther K (1991). Localization of Alzheimer βA4 amyloid at presynaptic terminals. Brain Res 563: 184-194.
130. Scott HL, Tannenberg AEG, and Dodd PR (1995). Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem 64:2193-2202.
131. Selkoe DJ (1989). Amyloid β protein precursor and the pathogenesis of Alzheimer's disease. Cell 58:611-612.
132. Selkoe DJ (1993). Physiological production of the β-amyloid protein and the mechanisms of Alzheimer's disease. Trends Neurosci 16:403-409.
133. Selkoe D (1994a). Cell biology of the amyloid β-protein precursor and the mechanisms of Alzheimer's disease. Annu Rev Cell Biol 10:373-403.
134. Selkoe DJ (1994b). Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci 17:489-517.
135. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, Mc-Cormack R, Wolfert R, Selkoe D, Lieberburg I, and Schenk D (1992). Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327.
136. Seubert P, Oltersdorf T, Lee M, Barbour R, Blomquist C, Davis D, Bryant K, Fritz L, Galasko D, Thal L, Lieberburg I, and Schenk D (1993). Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361:260-263.
137. Shashidharan P, Huntley GW, Meyer T, Morrison JH, and Platakis A (1994). Neuron-specific human gluatamate transporter: Molecular cloning, characterization and expression in human brain. Brain Res 662:245-250.
138. Shimokawa M, Yanagisawa K, Nishiye H, and Miyatake T (1993). Identification of amyloid precursor protein in synaptic plasma membrane. Biochem Biophys Res Commun 196: 240-244.
139. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai X-D, McKay DM, Tintner R, Frangione B, and Younkin SG (1992). Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258:126-129.
140. Sinha S, Dovey HF, Seubert P, Ward PJ, Blacher RW, Blaber M, Bradshaw RA, Arici M, Mobley WC, and Lieberburg I (1990). The protease inhibitory properties of the Alzheimer's beta-amyloid precursor protein. J Biol Chem 265:8983-8985.
141. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, and Price DL (1990). Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-494.
142. Sisodia SS and Price DL (1995). Role of the beta-amyloid protein in Alzheimer's disease. FASEB J 9:366-370.
143. Small DH, Nurcombe V, Moir R, Michaelson S, Monard D, Beyreuther K, and Masters CL (1992). Association and release of the amyloid protein precursor of Alzheimer's disease from chick brain extracellular matrix. J Neurosci 12:4143-4150.
144. Small DH, Nurcombe V, Reed G, Clarris H, Moir R, Beyreuther K, and Masters CL (1994). A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci 14:2117-2127.
145. Smith RP, Higuchi DA, and Broze GJ (1990). Platelet coagulation factor Xla-inhibitor, a form of Alzheimer amyloid precursor protein. Science 248:1126-1128.
146. Smith-Swintosky VL, Pettigrew LC, Craddock SD, Culwell AR, Rydel RE, and Mattson MP (1994). Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J Neurochem 63:781-784.
147. Soto C, Branes MC, Alvarez J, and Inestrosa NC (1994). Structural determinants of the Alzheimer's amyloid beta-peptide. J Neurochem 63:1191-1198.
148. Storck T, Schulte S, Hofman K, and Stoffel W (1992). Structure, expression, and functional analysis of a Na+-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89:10955-10959.
149. Strickland DK, Kounas MZ, and Argaves WS (1995). LDL receptor-related protein: A multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 9:890-898.
150. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, and Neve RL (1988). Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528-530.
151. Tanzi RE, Wenniger JJ, and Hyman BT (1993). Cellular specificity and regional distribution of amyloid beta protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation. Brain Res Mol Brain Res 18:246-252.
152. Terry RD and Wisniewski HM (1970). The ultrastructure of the neurofibrillary tangle and the senile plaque. In: Wolstenholme GEW and O'Connor M, editors. Ciba Foundation Symposium on Alzheimer's Disease and Related Conditions. London: J&A Churchill.
153. Terry RD, Peck A, DeTeresa R, Schechter R, and Horoupian DS (1981). Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184-192.
154. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, and Katzman R (1991). Physical basis of cognitive alterations in Alzheimer disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
155. Terry RD, Hansen L, and Masliah E (1994). Structural alterations in Alzheimer disease. In: Terry RD, and Katzman R, editors. Alzheimer's disease. New York: Raven Press.
156. Trapp BD, Hauer P, Haney C, and Wirak D (1992). APP is expressed in fetal brain and is associated with neuronal development (abstract). J Neuropathol Exp Neurol 51:358.
157. Van Nostrand WE, Wagner SL, Suzuki M, Choi BH, Farrow JS, Geddes JW, Cotman CW, and Cunningham DD (1989). Protease nexin-II, a potent antichymotripsin, shows identity to amyloid β protein. Nature 341:546-548.
158. Van Nostrand WE, Wagner SL, Farrow JS, and Cunningham DD (1990). Immunopurification and protease inhibitory properties of protease nexin-2/amyloid β-protein precursor. J Biol Chem 265:9591-9594.
159. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, and Price DL (1994). Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14:167-186.
160. Weiss JH, Pike CJ, and Cotman CW (1994). Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. J Neurochem 62:372-375.
161. Wragg M, Mutton M, Talbot C, and Alzheimer's Disease Collaborative Group (1996). Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347:509-512.
162. Yamaguchi H, Hirai S, Morimatso M, Shoji M, and Ihara Y (1988). A variety of cerebral amyloid deposits in the brains of Alzheimer-type dementia demonstrated by β-protein immunostaining. Acta Neuropathol 76:541-549.
163. Yamazaki T, Koo EH, and Selkoe DJ (1997). Cell surface amyloid β-protein precursor colocalizes with β1 integrins at substrate contact sites in neural cells. J Neurosci 17:1004-1010.
164. Yankner BA (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932.
165. Yankner BA, Duffy LK, and Kirschner DA (1990). Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250:279-282.
166. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJS, Hopkins R, Smith DW, Heavens RP, Dawson GR, Boyce S, Conner MW, Stevens KA, Slunt HH, Sisodia SS, Chen HY, and Van der Ploeg LHT (1995). β-amyloid precursor protein-deficient mice show reactive gliosis and decreased Iocomotor activity. Cell 81:525-531.